176 related articles for article (PubMed ID: 18406885)
21. Cumulative survival analysis of patients with spinal myxopapillary ependymomas in the first 2 decades of life.
Kukreja S; Ambekar S; Sin AH; Nanda A
J Neurosurg Pediatr; 2014 Apr; 13(4):400-7. PubMed ID: 24527863
[TBL] [Abstract][Full Text] [Related]
22. Proton radiotherapy for pediatric central nervous system ependymoma: clinical outcomes for 70 patients.
Macdonald SM; Sethi R; Lavally B; Yeap BY; Marcus KJ; Caruso P; Pulsifer M; Huang M; Ebb D; Tarbell NJ; Yock TI
Neuro Oncol; 2013 Nov; 15(11):1552-9. PubMed ID: 24101739
[TBL] [Abstract][Full Text] [Related]
23. Tumor control after surgery for spinal myxopapillary ependymomas: distinct outcomes in adults versus children: a systematic review.
Feldman WB; Clark AJ; Safaee M; Ames CP; Parsa AT
J Neurosurg Spine; 2013 Oct; 19(4):471-6. PubMed ID: 23971762
[TBL] [Abstract][Full Text] [Related]
24. Outcomes After Reirradiation for Recurrent Pediatric Intracranial Ependymoma.
Tsang DS; Burghen E; Klimo P; Boop FA; Ellison DW; Merchant TE
Int J Radiat Oncol Biol Phys; 2018 Feb; 100(2):507-515. PubMed ID: 29229328
[TBL] [Abstract][Full Text] [Related]
25. Re-irradiation of recurrent anaplastic ependymoma using radiosurgery or fractionated stereotactic radiotherapy.
Murai T; Sato K; Iwabuchi M; Manabe Y; Ogino H; Iwata H; Tatewaki K; Yokota N; Ohta S; Shibamoto Y
Jpn J Radiol; 2016 Mar; 34(3):211-8. PubMed ID: 26682738
[TBL] [Abstract][Full Text] [Related]
26. Treatment and outcome of children with relapsed ependymoma: a multi-institutional retrospective analysis.
Zacharoulis S; Ashley S; Moreno L; Gentet JC; Massimino M; Frappaz D
Childs Nerv Syst; 2010 Jul; 26(7):905-11. PubMed ID: 20039045
[TBL] [Abstract][Full Text] [Related]
27. Craniospinal irradiation as part of re-irradiation for children with recurrent intracranial ependymoma.
Tsang DS; Murray L; Ramaswamy V; Zapotocky M; Tabori U; Bartels U; Huang A; Dirks PB; Taylor MD; Hawkins C; Bouffet E; Laperriere N
Neuro Oncol; 2019 Mar; 21(4):547-557. PubMed ID: 30452715
[TBL] [Abstract][Full Text] [Related]
28. Extent of re-excision, sequence/timing of salvage re-irradiation, and disease-free interval impact upon clinical outcomes in recurrent/progressive ependymoma.
Gupta T; Maitre M; Gupta P; Krishnatry R; Chatterjee A; Moiyadi A; Shetty P; Singh V; Chinnaswamy G; Epari S; Sahay A; Patil V; GodaSastri J
J Neurooncol; 2020 Apr; 147(2):405-415. PubMed ID: 32072441
[TBL] [Abstract][Full Text] [Related]
29. A systematic review and meta-analysis of outcomes in pediatric, recurrent ependymoma.
Byer L; Kline CN; Coleman C; Allen IE; Whitaker E; Mueller S
J Neurooncol; 2019 Sep; 144(3):445-452. PubMed ID: 31502040
[TBL] [Abstract][Full Text] [Related]
30. Stereotactic radiosurgery for pediatric recurrent intracranial ependymomas.
Kano H; Yang HC; Kondziolka D; Niranjan A; Arai Y; Flickinger JC; Lunsford LD
J Neurosurg Pediatr; 2010 Nov; 6(5):417-23. PubMed ID: 21039163
[TBL] [Abstract][Full Text] [Related]
31. Outcomes of salvage re-irradiation in recurrent medulloblastoma correlate with age at initial diagnosis, primary risk-stratification, and molecular subgrouping.
Gupta T; Maitre M; Sastri GJ; Krishnatry R; Shirsat N; Epari S; Sahay A; Chinnaswamy G; Patil V; Shetty P; Moiyadi A
J Neurooncol; 2019 Sep; 144(2):283-291. PubMed ID: 31236820
[TBL] [Abstract][Full Text] [Related]
32. Conformal Radiation Therapy for Pediatric Ependymoma, Chemotherapy for Incompletely Resected Ependymoma, and Observation for Completely Resected, Supratentorial Ependymoma.
Merchant TE; Bendel AE; Sabin ND; Burger PC; Shaw DW; Chang E; Wu S; Zhou T; Eisenstat DD; Foreman NK; Fuller CE; Anderson ET; Hukin J; Lau CC; Pollack IF; Laningham FH; Lustig RH; Armstrong FD; Handler MH; Williams-Hughes C; Kessel S; Kocak M; Ellison DW; Ramaswamy V
J Clin Oncol; 2019 Apr; 37(12):974-983. PubMed ID: 30811284
[TBL] [Abstract][Full Text] [Related]
33. Re-irradiation of locally recurrent pediatric intracranial ependymoma: Experience of the French society of children's cancer.
Régnier E; Laprie A; Ducassou A; Bolle S; Supiot S; Muracciole X; Claude L; Chapet S; Coche-Dequéant B; Vigneron C; Leseur J; Bondiau PY; Habrand JL; Bernier V
Radiother Oncol; 2019 Mar; 132():1-7. PubMed ID: 30825956
[TBL] [Abstract][Full Text] [Related]
34. The evolving role of reirradiation in the management of recurrent brain tumors.
De Pietro R; Zaccaro L; Marampon F; Tini P; De Felice F; Minniti G
J Neurooncol; 2023 Sep; 164(2):271-286. PubMed ID: 37624529
[TBL] [Abstract][Full Text] [Related]
35. Review and update on pediatric ependymoma.
Boop SH; Shimony N; Boop FA
Childs Nerv Syst; 2023 Oct; 39(10):2667-2673. PubMed ID: 37493720
[TBL] [Abstract][Full Text] [Related]
36. Phase II study of everolimus for recurrent or progressive pediatric ependymoma.
Bowers DC; Rajaram V; Karajannis MA; Gardner SL; Su JM; Baxter P; Partap S; Klesse LJ
Neurooncol Adv; 2023; 5(1):vdad011. PubMed ID: 36950217
[TBL] [Abstract][Full Text] [Related]
37. Outcomes following management of relapsed pediatric posterior fossa ependymoma in the molecular era.
Malhotra AK; Nobre LF; Ibrahim GM; Kulkarni AV; Drake JM; Rutka JT; Bouffet E; Taylor MD; Tsang D; Ramaswamy V; Dirks PB; Dewan MC
J Neurooncol; 2023 Feb; 161(3):573-582. PubMed ID: 36757527
[TBL] [Abstract][Full Text] [Related]
38. The Positive Impact of a Chemotherapeutic Approach on Relapse Ependymoma or WHO Grade III Anaplastic Ependymoma: Report of a Rare Case.
Meghe A; Wanjari MB; Umalkar GN; Sharma R
Cureus; 2022 Dec; 14(12):e32534. PubMed ID: 36654551
[TBL] [Abstract][Full Text] [Related]
39. Molecular testing for adolescent and young adult central nervous system tumors: A Canadian guideline.
Lim-Fat MJ; Macdonald M; Lapointe S; Climans SA; Cacciotti C; Chahal M; Perreault S; Tsang DS; Gao A; Yip S; Keith J; Bennett J; Ramaswamy V; Detsky J; Tabori U; Das S; Hawkins C
Front Oncol; 2022; 12():960509. PubMed ID: 36249063
[TBL] [Abstract][Full Text] [Related]
40. Phase II study of intravenous etoposide in patients with relapsed ependymoma (CNS 2001 04).
Apps JR; Maycock S; Ellison DW; Jaspan T; Ritzmann TA; Macarthur D; Mallucci C; Wheatley K; Veal GJ; Grundy RG; Picton S
Neurooncol Adv; 2022; 4(1):vdac053. PubMed ID: 35591977
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
